[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  d_stock [@d_stock07734](/creator/twitter/d_stock07734) on x XXX followers Created: 2025-07-18 00:31:41 UTC In case someone has further interest, M7 protocol was mentioned in the following paper. With the breakthrough of this magnitude, should Merck acquire Oncovir and all the other ingredients complementary to DCVax-L long time ago, push $NWBO to bankruptcy, and pick up all the relevant IPs long time ago? It is just such a commonsense question some longs forgot to ask. Anatomy of a deal: How Merck closed Immune Design for $300M  XXXXX engagements  **Related Topics** [all the](/topic/all-the) [mayo](/topic/mayo) [$nwbo](/topic/$nwbo) [breakthrough](/topic/breakthrough) [protocol](/topic/protocol) [$mrk](/topic/$mrk) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/d_stock07734/status/1946004917379891543)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
d_stock @d_stock07734 on x XXX followers
Created: 2025-07-18 00:31:41 UTC
In case someone has further interest, M7 protocol was mentioned in the following paper.
With the breakthrough of this magnitude, should Merck acquire Oncovir and all the other ingredients complementary to DCVax-L long time ago, push $NWBO to bankruptcy, and pick up all the relevant IPs long time ago? It is just such a commonsense question some longs forgot to ask.
Anatomy of a deal: How Merck closed Immune Design for $300M
XXXXX engagements
Related Topics all the mayo $nwbo breakthrough protocol $mrk stocks healthcare
/post/tweet::1946004917379891543